Literature DB >> 16823896

Primary testicular diffuse large B-cell lymphomas have activated B-cell-like subtype characteristics.

M Booman1, J Douwes, A M Glas, D de Jong, E Schuuring, P M Kluin.   

Abstract

Diffuse large B-cell lymphomas (DLBCLs) constitute a heterogeneous group of lymphomas in which germinal centre B-cell-like and activated B-cell-like subtypes can be discerned based on pathology, clinical presentation, and gene expression patterns. Testicular DLBCLs form an immune-privileged site-related subgroup of DLBCLs with an unfavourable prognosis. In the present study, cDNA microarray analysis, immunohistochemistry for CD10, Bcl6 and MUM1, and somatic hypermutation analysis of the immunoglobulin heavy chain gene rearrangements were used to determine the subtype of primary testicular DLBCL. Immunohistochemistry revealed 14/22 testicular DLBCLs with an activated B-cell-like immunophenotype and 8/22 with an ambiguous immunophenotype co-expressing CD10 and high levels of MUM1. cDNA microarray analysis of these 22 and four additional cases showed a uniform activated B-cell-like gene expression pattern for both immunophenotypes. Somatic hypermutation analysis of immunoglobulin heavy chain genes showed a very high mutation load in seven cases tested, but intraclonal heterogeneity was found at low level in only one of these cases. It is concluded that primary testicular DLBCLs have uniform activated B-cell-like subtype characteristics despite a number of cases showing an ambiguous immunophenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16823896     DOI: 10.1002/path.2033

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

1.  Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma.

Authors:  Sarah T Wilkinson; Kristie A Vanpatten; Diane R Fernandez; Patrick Brunhoeber; Karl E Garsha; Betty J Glinsmann-Gibson; Thomas M Grogan; Julie Teruya-Feldstein; Lisa M Rimsza
Journal:  Blood       Date:  2011-12-13       Impact factor: 22.113

2.  Low levels of monoclonal small B cells in the bone marrow of patients with diffuse large B-cell lymphoma of activated B-cell type but not of germinal center B-cell type.

Authors:  Anne M Tierens; Harald Holte; Abdirashid Warsame; Ida M Ikonomou; Junbai Wang; Wing C Chan; Jan Delabie
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

3.  Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium.

Authors:  L Deng; Z Y Xu-Monette; S Loghavi; G C Manyam; Y Xia; C Visco; J Huh; L Zhang; Q Zhai; Y Wang; L Qiu; K Dybkær; A Chiu; A M Perry; S Zhang; A Tzankov; H Rao; J Abramson; A R Sohani; M Xu; E D Hsi; J Zhu; M Ponzoni; S Wang; Ling Li; M Zhang; A J M Ferreri; B M Parsons; Y Li; M A Piris; L J Medeiros; K H Young
Journal:  Leukemia       Date:  2013-08-26       Impact factor: 11.528

4.  Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era.

Authors:  Anita Kumar; Matthew A Lunning; Zhigang Zhang; Jocelyn C Migliacci; Craig H Moskowitz; Andrew D Zelenetz
Journal:  Br J Haematol       Date:  2015-10-12       Impact factor: 6.998

5.  High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites.

Authors:  W Kraan; H M Horlings; M van Keimpema; E J M Schilder-Tol; M E C M Oud; C Scheepstra; P M Kluin; M J Kersten; M Spaargaren; S T Pals
Journal:  Blood Cancer J       Date:  2013-09-06       Impact factor: 11.037

6.  Treatment of primary testicular diffuse large B cell lymphoma without prophylactic intrathecal chemotherapy: a single center experience.

Authors:  Jeongseok Kim; Dok Hyun Yoon; Inkeun Park; Shin Kim; Jung Sun Park; Sang-Wook Lee; Jooryung Huh; Chan-Sik Park; Cheolwon Suh
Journal:  Blood Res       Date:  2014-09-25

7.  Metachronous extranodal natural killer/T-cell lymphoma of nasal type and primary testicular lymphoma.

Authors:  Young-In Maeng; Sun-Jae Lee
Journal:  Yeungnam Univ J Med       Date:  2020-09-11

8.  Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma.

Authors:  Keren Isaev; Daisuke Ennishi; Laura Hilton; Brian Skinnider; Karen L Mungall; Andrew J Mungall; Mehran Bakhtiari; Rosemarie Tremblay-LeMay; Anjali Silva; Susana Ben-Neriah; Merrill Boyle; Diego Villa; Marco A Marra; Christian Steidl; Randy D Gascoyne; Ryan Morin; Kerry J Savage; David W Scott; Robert Kridel
Journal:  Haematologica       Date:  2021-05-01       Impact factor: 9.941

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.